Expression of osteopontin by exudate macrophages in inflammatory tissues of the middle ear: A possible association with development of tympanosclerosis

Hearing Research

Volumn 153, Issue 1-2, 2001, Pages 100-107

  Makiishi Shimobayashi, Chiaki ^a   Tsujimura, Tohru ^a   Sugihara, Ayako ^a   Iwasaki, Teruo ^a   Yamada, Naoko ^a   Terada, Nobuyuki ^a   Sakagami, Masafumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Calcification; Chronic otitis media; Macrophage; Osteopontin; Tympanosclerosis

Indexed keywords

CHLORDANE; MESSENGER RNA; OSTEOPONTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIFICATION; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; CONTROLLED STUDY; EARDRUM; EXUDATE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MIDDLE EAR MUCOSA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLEROSIS;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD, PRESCHOOL; DNA PRIMERS; EAR, MIDDLE; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MACROPHAGES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; OSTEOPONTIN; OTITIS MEDIA; RNA, MESSENGER; SCLEROSIS; SIALOGLYCOPROTEINS; TYMPANIC MEMBRANE;

EID: 0035137661     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(00)00260-4     Document Type: Article

References (30)

1. Osteopontin expression and distribution in human carcinomas
2. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone
3. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes
4. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule
5. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
6. The minigrommet and tympanosclerosis
7. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification
8. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers: possible involvement of osteopontin in development of calcifying foci
9. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation
10. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification
11. Functional analysis of the osteopontin molecule
12. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin
13. Tympanosclerosis: a scanning electron microscopic study
14. Detection of osteopontin in calcified human aortic valves
15. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
16. Osteopontin is expressed in human aortic valvular lesions: evidence that aortic valve calcification may be actively regulated
17. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence
18. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histologic and immunohistochemical studies
19. Intratympanic membrane bleeding after grommet insertion and tympanosclerosis
20. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression
21. 3 potentiate bone resorption
22. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques
23. Tympanosclerosis
24. Histology of tympanosclerosis
25. Hearing loss in tympanosclerosis caused by grommets
26. Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping' method
27. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin
28. Tympanosclerosis